Table 3. Associations of Leptin with Incident Cardiovascular Disease in Inter99.
Model 1 (n = 5,854) | Model 2 (n = 5,800) | Model 3 (n = 5,763) | ||||
---|---|---|---|---|---|---|
Events | HR (95% CI) | Events | HR (95% CI) | Events | HR (95% CI) | |
Combined events | 464 | 1.17 (1.07–1.28)* | 457 | 1.02 (0.93–1.13) | 453 | 0.97 (0.85–1.12) |
IHD | 303 | 1.18 (1.05–1.32)* | 299 | 0.98 (0.87–1.11) | 297 | 0.95 (0.80–1.12) |
Stroke | 182 | 1.15 (0.99–1.33) | 181 | 1.10 (0.94–1.29) | 179 | 1.08 (0.87–1.35) |
Data are presented as Hazard Ratio per one standard deviation increase in log transformed leptin level. Model 1: Adjusted for sex, age and intervention group. Model 2: Model 1 + total cholesterol, HDL-cholesterol, smoking status, systolic blood pressure, treatment for hypertension and baseline diabetes. Model 3: Model 2 + BMI, HOMA-IR, eGFR, CRP and adiponectin.
*P <0.01